GRDN Guardian Pharmacy Services, Inc. stock chart & analysis
Conviction 63Consumer StaplesScan · Fri, Nov 6, 2026Guardian Pharmacy Services, Inc. (GRDN) closed at $42.39 (+6.32%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 57, RS Rating 90, -12.2% from its 52-week high, +41.0% year to date. Sector: Consumer Staples · Medical Care Facilities.
Financials as of Wed, Sep 30, 2026 · quarterly.
GRDN technical analysis
Trend
GRDN is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 2.5% above the 50-day ($41.40) and 10.6% above the 200-day ($38.38). ADX(14) at 15 points to a weak trend — more range than direction. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 57, in the bullish half of its range. MACD crossed above its signal line 6 sessions ago. A bullish MACD divergence is in place. Its RS Rating of 90 puts its weighted 12-month performance ahead of about 90% of the US market.
Volume and volatility
Volume on the latest session ran 5.1× its 20-day average. It trades about $20.1M a day on average. ATR(14) is $1.70, 4.0% of price — its typical daily range. Bollinger Bands are in a squeeze (14 sessions) — volatility is compressed. On-balance volume is trending up. Chaikin Money Flow (0.12) shows accumulation.
Key levels
The chart pattern's support is $38.94 and its resistance $45.64. The 52-week range is $26.34 to $48.33; price is 12.2% below the high and 61.1% above the low. The VWAP anchored at the 52-week high is $42.11, below price.
Performance
GRDN returned +4.3% (1 week), +2.0% (1 month), +2.3% (3 months), +17.6% (6 months), +46.4% (1 year), +41.0% (year to date).
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
Medical Care Facilities · Listed 2024 · 3,600 employees
Insider activity
SEC Form 4 transactions in GRDN
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
COSLER STEVEN D Director · Class A Common Stock · 2026-05-05 | Grant | 4.03K | $0 | 2026-05-05 | 2026-05-07 |
LEWIS RANDALL J Director · Class A Common Stock · 2026-05-05 | Grant | 4.03K | $0 | 2026-05-05 | 2026-05-07 |
Patchett Mary Sue Director · Class A Common Stock · 2026-05-05 | Grant | 4.03K | $0 | 2026-05-05 | 2026-05-07 |
SEC filings
EDGAR filings in GRDN · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.